Genetic changes of non-small cell lung cancer under neoadjuvant therapy

BACKGROUND: Large scale sequencing efforts defined common molecular alterations in non-small cell lung cancer (NSCLC) and revealed potentially druggable mutations. Yet, systematic data on the changes of the respective molecular profiles under standard therapy in NSCLC are limited. RESULTS: 14 out of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Warth, Arne, Endris, Volker, Stenzinger, Albrecht, Penzel, Roland, Harms, Alexander, Duell, Thomas, Abdollahi, Amir, Lindner, Michael, Schirmacher, Peter, Muley, Thomas, Dienemann, Hendrik, Fink, Ludger, Morresi-Hauf, Alicia, Pfarr, Nicole, Weichert, Wilko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045431/
https://ncbi.nlm.nih.gov/pubmed/27105513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8858
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller